Eder Therapeutics is made for Canadians by Canadians. We recognize Canada's multiculturalism as a reflection of our society's richness, and our goal is to develop new treatment options within Canada that address the specific needs and health concerns of different communities within the rare disease space.

 

Our expertise in the Canadian market, combined with an efficient scalable operating model with expert partners, allows us to bring rare disease therapies to market that may not have launched otherwise. Globally, our mission is to deliver Canadian innovation to patients across the world.

 

Through our commitment to celebrating diversity within Canada, we aim to make a positive impact on the lives of all individuals, families, and communities affected by rare diseases. We believe that by embracing and respecting our differences, we can collectively contribute to a healthier, more inclusive future for all.